SITC Archive Library

SITC 2019 Annual Meeting: Session 100: Lessons and Challenges from the Immunotherapy of Hematologic Malignancies: Informing the Next Generation of Cancer Immunotherapies 

10-23-2019 10:45

The Society for Immunotherapy of Cancer (SITC) hosted "Session 100: Lessons and Challenges from the Immunotherapy of Hematologic Malignancies: Informing the Next Generation of Cancer Immunotherapies" during the SITC 2019 Annual Meeting on November 7, 2019. This session was organized in collaboration with the American Society of Hematology (ASH). Available here are the presentation slides and video from the session.

34th Annual Meeting Organizers

  • Ana Carrizosa Anderson, PhD – Harvard Medical School
  • Marianne Davies, DNP, AOCNP – Yale School of Nursing
  • Stefani Spranger, PhD – Koch Institute for Integrative Cancer Research at MIT
  • Ahmad A. Tarhini, MD, PhD – Emory University and Winship Comprehensive Cancer Center


Session Co-Chairs

  • Katayoun Rezvani, MD, PhD – The University of Texas MD Anderson Cancer Center
  • John M. Timmerman, MD – University of California, Los Angeles

Session Summary

In the past decade, the field of cellular therapy has emerged as a powerful treatment modality for advanced cancers refractory to conventional therapy. Genetic engineering of immune cells has evolved from a promising concept to a practical solution for the treatment of a number of previously refractory types of cancer. These exciting new therapies mark a paradigm shift in the treatment of certain hematologic malignancies, and are expected to cause a ripple effect in the field of cellular therapy and gene editing to target other cancers.

As hematologic malignancies have been on the frontline of developing novel cell-based immunotherapies with amongst the best response rates, this workshop focused on lessons learned from these trials and how they can inform the design of next-generation clinical studies. Presentations by leaders in the field provided an opportunity for attendees to gain a deeper understanding of the predictors and mechanisms of tumor escape, the contribution of the tumor microenvironment, and how this knowledge can be used for the development of novel immune therapeutic agents for the treatment of all types of cancer.

To view the entire program schedule (including presenter permission to post) please click here.

Statistics
0 Favorited
165 Views
11 Files
0 Shares
448 Downloads

 Video
Attachment(s)
pdf file
"Annual Meeting Welcome" - Presentation Slides   822 KB   1 version
Uploaded - 11-08-2019
Meeting: SITC 34th Annual Meeting; Session 100: Lessons and Challenges from the Immunotherapy of Hematologic Malignancies: Informing the Next Generation of Cancer Immunotherapies; Presenter: Sandra Demaria, MD – Weill Cornell Medicine; Date: November 7, 2019
pdf file
"Lessons and Challenges from the Immunotherapy of Lymphom...   4.74 MB   1 version
Uploaded - 11-08-2019
Meeting: SITC 34th Annual Meeting; Session 100: Lessons and Challenges from the Immunotherapy of Hematologic Malignancies: Informing the Next Generation of Cancer Immunotherapies; Presenter: Stephen Ansell, MD, PhD – Mayo Clinic; Date: November 7, 2019
mp4 file
"Lessons and Challenges from the Immunotherapy of Lymphom...   437.85 MB   1 version
Uploaded - 12-03-2019
Meeting: SITC 34th Annual Meeting; Session 100: Lessons and Challenges from the Immunotherapy of Hematologic Malignancies: Informing the Next Generation of Cancer Immunotherapies; Presenter: Stephen Ansell, MD, PhD – Mayo Clinic; Date: November 7, 2019
pdf file
"Immune infiltration correlates with TP53 mutational stat...   3.15 MB   1 version
Uploaded - 11-08-2019
Meeting: SITC 34th Annual Meeting; Session 100: Lessons and Challenges from the Immunotherapy of Hematologic Malignancies: Informing the Next Generation of Cancer Immunotherapies; Presenter: Sergio Rutella, MD, PhD, FRCPath – Nottingham Trent University; Date: November 7, 2019
mp4 file
"Immune infiltration correlates with TP53 mutational stat...   227.40 MB   1 version
Uploaded - 12-03-2019
Meeting: SITC 34th Annual Meeting; Session 100: Lessons and Challenges from the Immunotherapy of Hematologic Malignancies: Informing the Next Generation of Cancer Immunotherapies; Presenter: Sergio Rutella, MD, PhD, FRCPath – Nottingham Trent University; Date: November 7, 2019
pdf file
"Immune profiling of the tumor microenvirnoment in classi...   1.71 MB   1 version
Uploaded - 11-08-2019
Meeting: SITC 34th Annual Meeting; Session 100: Lessons and Challenges from the Immunotherapy of Hematologic Malignancies: Informing the Next Generation of Cancer Immunotherapies; Presenter: El-ad David Amir, PhD – Astrolabe Diagnostics, Inc.; Date: November 7, 2019
mp4 file
"Immune profiling of the tumor microenvirnoment in classi...   217.51 MB   1 version
Uploaded - 12-03-2019
Meeting: SITC 34th Annual Meeting; Session 100: Lessons and Challenges from the Immunotherapy of Hematologic Malignancies: Informing the Next Generation of Cancer Immunotherapies; Presenter: El-ad David Amir, PhD – Astrolabe Diagnostics, Inc.; Date: November 7, 2019
pdf file
"Addressing Relapse After CAR T cell Therapy for B cell M...   4.47 MB   1 version
Uploaded - 11-08-2019
Meeting: SITC 34th Annual Meeting; Session 100: Lessons and Challenges from the Immunotherapy of Hematologic Malignancies: Informing the Next Generation of Cancer Immunotherapies; Presenter: Terry Fry, MD – University of Colorado School of Medicine, Children's Hospital Colorado; Date: November 7, 2019
mp4 file
"Addressing Relapse After CAR T cell Therapy for B cell M...   511.24 MB   1 version
Uploaded - 12-03-2019
Meeting: SITC 34th Annual Meeting; Session 100: Lessons and Challenges from the Immunotherapy of Hematologic Malignancies: Informing the Next Generation of Cancer Immunotherapies; Presenter: Terry Fry, MD – University of Colorado School of Medicine, Children's Hospital Colorado; Date: November 7, 2019
pdf file
"Enhancing affinity of CD22-directed CAR T cells increase...   1.72 MB   1 version
Uploaded - 11-08-2019
Meeting: SITC 34th Annual Meeting; Session 100: Lessons and Challenges from the Immunotherapy of Hematologic Malignancies: Informing the Next Generation of Cancer Immunotherapies; Presenter: Zachary Walsh, BA – Children's Hospital Colorado; Date: November 7, 2019
mp4 file
"Enhancing affinity of CD22-directed CAR T cells increase...   219.63 MB   1 version
Uploaded - 12-03-2019
Meeting: SITC 34th Annual Meeting; Session 100: Lessons and Challenges from the Immunotherapy of Hematologic Malignancies: Informing the Next Generation of Cancer Immunotherapies; Presenter: Zachary Walsh, BA – Children's Hospital Colorado; Date: November 7, 2019

Related Entries and Links

No Related Resource entered.